177 related articles for article (PubMed ID: 11457995)
81. Foetal infections with bovine viral diarrhoea virus in Argentina.
Muñoz DP; Lager IA; Mersich S; Zábal O; Ulloa E; Schudel AA; Weber EL
Br Vet J; 1996 Mar; 152(2):175-82. PubMed ID: 8680840
[TBL] [Abstract][Full Text] [Related]
82. Induction of mucosal disease in cattle persistently infected with noncytopathic bovine viral diarrhea-mucosal disease virus by superinfection with cytopathic bovine viral diarrhea-mucosal disease virus.
Nakajima N; Fukuyama S; Hirahara T; Takamura K; Okada N; Kawazu K; Ui S; Kodama K
J Vet Med Sci; 1993 Feb; 55(1):67-72. PubMed ID: 8384896
[TBL] [Abstract][Full Text] [Related]
83. Pathogenesis of transplacental virus infection: pestivirus replication in the placenta and fetus following respiratory infection.
Swasdipan S; McGowan M; Phillips N; Bielefeldt-Ohmann H
Microb Pathog; 2002 Feb; 32(2):49-60. PubMed ID: 11812211
[TBL] [Abstract][Full Text] [Related]
84. Pathogenicity of a bovine viral diarrhoea virus strain in pregnant sows: short communication.
Kulcsár G; Soós P; Kucsera L; Glávits R; Pálfi V
Acta Vet Hung; 2001; 49(1):117-20. PubMed ID: 11402685
[TBL] [Abstract][Full Text] [Related]
85. Experimental infection of pregnant cows with noncytopathogenic bovine viral diarrhoea virus between days 26 and 50 postbreeding.
Tsuboi T; Osawa T; Hirata TI; Kawashima K; Kimura K; Haritani M
Res Vet Sci; 2013 Jun; 94(3):803-5. PubMed ID: 23261157
[TBL] [Abstract][Full Text] [Related]
86. Failure of foetal protection after vaccination against an experimental infection with bovine virus diarrhea virus.
Zimmer GM; Wentink GH; Bruschke C; Westenbrink FJ; Brinkhof J; de Goey I
Vet Microbiol; 2002 Nov; 89(4):255-65. PubMed ID: 12383635
[TBL] [Abstract][Full Text] [Related]
87. Masking of two in vitro immunological assays for Mycobacterium bovis (BCG) in calves acutely infected with non-cytopathic bovine viral diarrhoea virus.
Charleston B; Hope JC; Carr BV; Howard CJ
Vet Rec; 2001 Oct; 149(16):481-4. PubMed ID: 11700926
[TBL] [Abstract][Full Text] [Related]
88. Bovine viral diarrhoea: pathogenesis and diagnosis.
Lanyon SR; Hill FI; Reichel MP; Brownlie J
Vet J; 2014 Feb; 199(2):201-9. PubMed ID: 24053990
[TBL] [Abstract][Full Text] [Related]
89. Protective effect of an ISCOM bovine virus diarrhoea virus (BVDV) vaccine against an experimental BVDV infection in vaccinated and non-vaccinated pregnant ewes.
Carlsson U; Alenius S; Sundquist B
Vaccine; 1991 Aug; 9(8):577-80. PubMed ID: 1663302
[TBL] [Abstract][Full Text] [Related]
90. Transplacental infection with non-cytopathic bovine viral diarrhoea virus types 1b and 2: viral spread and molecular neuropathology.
Bielefeldt-Ohmann H; Tolnay AE; Reisenhauer CE; Hansen TR; Smirnova N; Van Campen H
J Comp Pathol; 2008; 138(2-3):72-85. PubMed ID: 18295788
[TBL] [Abstract][Full Text] [Related]
91. The pathogenesis of bovine virus diarrhoea virus infections.
Brownlie J
Rev Sci Tech; 1990 Mar; 9(1):43-59. PubMed ID: 2132154
[TBL] [Abstract][Full Text] [Related]
92. Percutaneous collection of fetal fluids for detection of bovine viral diarrhea virus infection in cattle.
Callan RJ; Schnackel JA; Van Campen H; Mortimer RG; Cavender JA; Williams ES
J Am Vet Med Assoc; 2002 May; 220(9):1348-52. PubMed ID: 11991414
[TBL] [Abstract][Full Text] [Related]
93. Tissue distribution of bovine viral diarrhea virus antigens in persistently infected cattle.
Shin T; Acland H
J Vet Sci; 2001 Aug; 2(2):81-4. PubMed ID: 14614275
[TBL] [Abstract][Full Text] [Related]
94. Differential effects of bovine viral diarrhoea virus on monocytes and dendritic cells.
Glew EJ; Carr BV; Brackenbury LS; Hope JC; Charleston B; Howard CJ
J Gen Virol; 2003 Jul; 84(Pt 7):1771-1780. PubMed ID: 12810871
[TBL] [Abstract][Full Text] [Related]
95. Persistent fetal infection with bovine viral diarrhea virus differentially affects maternal blood cell signal transduction pathways.
Smirnova NP; Ptitsyn AA; Austin KJ; Bielefeldt-Ohmann H; Van Campen H; Han H; van Olphen AL; Hansen TR
Physiol Genomics; 2009 Feb; 36(3):129-39. PubMed ID: 19018046
[TBL] [Abstract][Full Text] [Related]
96. The immune response to bovine viral diarrhea virus: a constantly changing picture.
Chase CC; Elmowalid G; Yousif AA
Vet Clin North Am Food Anim Pract; 2004 Mar; 20(1):95-114. PubMed ID: 15062477
[TBL] [Abstract][Full Text] [Related]
97. BVDV-1 induces interferon-beta gene expression through a pathway involving IRF1, IRF7, and NF-κB activation.
Maldonado N; Fredericksen F; Espiñeira C; Toledo C; Oltra J; la Barra V; Fernandez C; Salvador J; Villalba M; Olavarría VH
Mol Immunol; 2020 Dec; 128():33-40. PubMed ID: 33053462
[TBL] [Abstract][Full Text] [Related]
98. Neuro-invasion by a 'Trojan Horse' strategy and vasculopathy during intrauterine flavivirus infection.
Bielefeldt-Ohmann H; Smirnova NP; Tolnay AE; Webb BT; Antoniazzi AQ; van Campen H; Hansen TR
Int J Exp Pathol; 2012 Feb; 93(1):24-33. PubMed ID: 22264283
[TBL] [Abstract][Full Text] [Related]
99. Comparison of the Ability of High and Low Virulence Strains of Non-cytopathic Bovine Viral Diarrhea Virus-1 to Modulate Expression of Interferon Tau Stimulated Genes in Bovine Endometrium.
Wang K; Thomas C; Zhang S; Wathes DC; Cheng Z
Front Vet Sci; 2021; 8():659330. PubMed ID: 33898551
[TBL] [Abstract][Full Text] [Related]
100. Macrophages infected with cytopathic bovine viral diarrhea virus release a factor(s) capable of priming uninfected macrophages for activation-induced apoptosis.
Adler B; Adler H; Pfister H; Jungi TW; Peterhans E
J Virol; 1997 Apr; 71(4):3255-8. PubMed ID: 9060690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]